RESUMEN
Bleeding disorders are commonly associated with hemato-oncologic diseases. We report a 68 years old male with a chronic myelomonocytic leukemia derived from a long lasting mielodysplastic syndrome that did not respond to treatment with Azacitidine. The patient was hospitalized due to tonic clonic seizures. A CAT scan showed a hematoma in the frontal lobe. A new assessment of hemostasis revealed an isolated deficiency of Factor X. We speculate that this deficit could be secondary to consumption due to the chronic Myelomonocytic Leukemia.
Asunto(s)
Anciano , Humanos , Masculino , Deficiencia del Factor X/etiología , Lóbulo Frontal/lesiones , Leucemia Mielomonocítica Crónica/complicaciones , Antimetabolitos Antineoplásicos/uso terapéutico , Azacitidina/uso terapéutico , Deficiencia del Factor X/diagnóstico , Hematoma/diagnóstico , Leucemia Mielomonocítica Crónica/tratamiento farmacológico , Leucocitos , Monocitos , Convulsiones/complicacionesRESUMEN
Bleeding disorders are commonly associated with hemato-oncologic diseases. We report a 68 years old male with a chronic myelomonocytic leukemia derived from a long lasting mielodysplastic syndrome that did not respond to treatment with Azacitidine. The patient was hospitalized due to tonic clonic seizures. A CAT scan showed a hematoma in the frontal lobe. A new assessment of hemostasis revealed an isolated deficiency of Factor X. We speculate that this deficit could be secondary to consumption due to the chronic Myelomonocytic Leukemia.